Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome: Randomized Controlled Trial
Latest Information Update: 22 Jan 2025
Price :
$35 *
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 22 Jan 2025 New trial record